Glaxo Smith Kline
Last Updated:
- 71.12 EGP
- -0.70
- -0.97%
جلاكسو سميثكلاين
جلاكسو سميثكلاين
Symbol :
BIOC
ISIN :
EGS38171C012
52-Week Range :
36.00
-
81.50
Turnover Ratio :
0.40
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Top News
- A 16-November GSK Egypt posts lower consolidated net profits at EGP 30m in 9M-25
- B 14-August GSK Egypt’s consolidated net profits shrink to EGP 65m in H1-25
- C 19-November GSK Egypt posts EGP 106m consolidated profits in 9M-24
- D 19-August GSK Egypt’s net profits hike in H1-24
- E 15-May GSK Egypt turns to loss in Q1-24
- F 30-April GSK Egypt obtains shareholders’ nod for 2023 cash dividends
- G 04-March GSK Egypt’s consolidated profits plunge to EGP 60m in 2023; dividends approved
- H 19-November GSK Egypt records plunge in 9M-23 profits; sales hit EGP 1.57bn
- I 16-August GSK Egypt’s net profits shrink in H1-23 results
- J 01-June GSK Egypt generates lower consolidated profits in Q1-23
- K 04-May GSK Egypt’s shareholders approve 2022 cash dividends
- L 03-April GSK Egypt records 376% leap in 2022 consolidated profits; dividends announced
